Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Spriggs

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|August 25, 2001
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patientsM L Hensley, B Hoppe, L Leon, et al.
Cancer Research|November 15, 1990
Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factorD R Spriggs, M L Sherman, K Imamura, et al.
Gynecologic Oncology|March 30, 2001
Complications associated with intraperitoneal chemotherapy cathetersS Makhija, M Leitao, P Sabbatini, et al.
Blood|July 1, 1989
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humansK A Bauer, H ten Cate, S Barzegar, et al.
American Journal of Clinical Oncology|April 1, 1993
Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromesR M Stone, D R Spriggs, K A Arthur, et al.
Annals of Surgery|October 1, 1988
Interleukin-2 initiates metabolic responses associated with critical illness in humansH R Michie, T J Eberlein, D R Spriggs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivoG D Demetri, D R Spriggs, M L Sherman, et al.
Leukemia|December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemiaR M Stone, D R Spriggs, R K Dhawan, et al.
Cancer Communications|January 1, 1989
Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cellsS M Kharbanda, K Miyazaki, H Takeyama, et al.
Cancer Letters|February 10, 1995
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermiaH I Robins, F d'Oleire, M Kutz, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|August 25, 2001
The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patientsM L Hensley, B Hoppe, L Leon, et al.
Cancer Research|November 15, 1990
Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factorD R Spriggs, M L Sherman, K Imamura, et al.
Gynecologic Oncology|March 30, 2001
Complications associated with intraperitoneal chemotherapy cathetersS Makhija, M Leitao, P Sabbatini, et al.
Blood|July 1, 1989
Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humansK A Bauer, H ten Cate, S Barzegar, et al.
American Journal of Clinical Oncology|April 1, 1993
Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromesR M Stone, D R Spriggs, K A Arthur, et al.
Annals of Surgery|October 1, 1988
Interleukin-2 initiates metabolic responses associated with critical illness in humansH R Michie, T J Eberlein, D R Spriggs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1989
A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivoG D Demetri, D R Spriggs, M L Sherman, et al.
Leukemia|December 1, 1990
A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemiaR M Stone, D R Spriggs, R K Dhawan, et al.
Cancer Communications|January 1, 1989
Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cellsS M Kharbanda, K Miyazaki, H Takeyama, et al.
Cancer Letters|February 10, 1995
Cytotoxic interactions of tumor necrosis factor, melphalan and 41.8 degrees C hyperthermiaH I Robins, F d'Oleire, M Kutz, et al.
Pageof 10